Skip to main navigation Skip to search Skip to main content

CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)1122-1126
Number of pages5
JournalJournal of investigative dermatology
Volume143
Issue number7
DOIs
Publication statusPublished - Jul 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fields of science

  • 302 Clinical Medicine

Cite this